Polaris Quantum Biotech Inc. (Polarisqb) ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Revolutionizing drug design with quantum computing, AI, and machine learning to accelerate the discovery of novel drug leads.

Healthcare
Active
Durham, United States Founded 2019
Last updated 2026-08-21
Total raised
$891K
Stage
—
Founded
2019
Headcount
—
HQ
Durham, United States
Sector
Healthcare

About

POLARISqb is a quantum software company that uses quantum computing and artificial intelligence to process, evaluate, and identify drug lead molecules 10,000 times faster than alternative solutions. The company's platform, QuADD (Quantum-Aided Drug Design), combines quantum annealing, advanced AI, and molecular modeling to explore vast chemical spaces, perform multi-objective molecular optimization, and deliver prioritized, synthesizable candidates to biopharma partners across therapeutic areas. POLARISqb aims to dramatically decrease the time and costs associated with early drug discovery, enabling the development of treatments for previously untreatable diseases.

Funding history · 2 rounds · $891K total

2 events/rounds · $891K Total Funding: $891K in Private Equity
Dec 2021
Seed Extension $891K TASE ↗
May 2021
Seed Undisclosed TASE ↗

Offices

Durham, United States · HQ / main office

Q&A

What is Polaris Quantum Biotech Inc. (Polarisqb)'s primary focus?
Polaris Quantum Biotech Inc. (Polarisqb) is a quantum software company that utilizes quantum computing and artificial intelligence to accelerate drug discovery by identifying drug lead molecules significantly faster than traditional methods.
When was Polaris Quantum Biotech Inc. (Polarisqb) founded?
Polaris Quantum Biotech Inc. (Polarisqb) was founded in 2019.
Where is Polaris Quantum Biotech Inc. (Polarisqb) headquartered?
Polaris Quantum Biotech Inc. (Polarisqb) is headquartered in Durham, United States.
What is the name of Polaris Quantum Biotech Inc. (Polarisqb)'s core platform?
Polaris Quantum Biotech Inc. (Polarisqb)'s core platform is called QuADD (Quantum-Aided Drug Design), which combines quantum annealing, advanced AI, and molecular modeling.
Who are the co-founders of Polaris Quantum Biotech Inc. (Polarisqb)?
The co-founders of Polaris Quantum Biotech Inc. (Polarisqb) are Shahar Keinan, who serves as CEO, and Bill Shipman, who serves as CTO. Both joined in 2020.
What is the total amount of funding Polaris Quantum Biotech Inc. (Polarisqb) has raised?
Polaris Quantum Biotech Inc. (Polarisqb) has raised a total of $891,000 in funding.
When did Polaris Quantum Biotech Inc. (Polarisqb) complete its Seed Extension funding round?
Polaris Quantum Biotech Inc. (Polarisqb) completed a Seed Extension funding round in December 2021, raising $891,000.
What technologies does Polaris Quantum Biotech Inc. (Polarisqb) primarily use?
Polaris Quantum Biotech Inc. (Polarisqb) primarily uses Quantum Computing, Artificial Intelligence, Machine Learning, Cloud Computing, and Molecular Modeling.

Sectors & technology

Primary sector
Healthcare
Technologies
Target customers
Business model
SaaS
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepolarisqb.com

Identifiers & details

Founded2019

Radar intelligence

Web history (Wayback)

Domainpolarisqb.com